Patrick Brueck

Patrick Brueck is a highly experienced professional in clinical development and medical affairs, currently serving as Sr. Director of Clinical Development at BioNTech SE since July 2020. Prior to this role, Brueck was a Senior Medical Advisor at Boehringer Ingelheim and a Medical Advisor at Eli Lilly and Company, focusing on oncology and hematology, as well as product launches and health technology assessment. Brueck's earlier positions include Senior Physician/Consultant at Justus-Liebig University Giessen, where responsibilities involved overseeing clinical trials in multiple myeloma and establishing an oncology unit, and a Resident Physician in both medical oncology and pathologic anatomy at prominent universities. Brueck holds an MBA in Pharmaceutical Economics from Goethe University Frankfurt and an M.D. from Heidelberg University.